LNTH Long Put Strategy
LNTH (Lantheus Holdings, Inc.), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NASDAQ.
Lantheus Holdings, Inc. is a global pharmaceutical company dedicated to the development, manufacturing, and commercialization of advanced diagnostic and therapeutic agents. Their mission is to empower clinicians worldwide in the accurate diagnosis and effective treatment of a wide spectrum of conditions, particularly heart disease, various cancers, and other serious illnesses. Their current diagnostic portfolio features several key products: DEFINITY, a microbubble ultrasound contrast agent for cardiac evaluations; TechneLite, a technetium generator essential for nuclear medicine; Xenon-133, used to assess pulmonary function; Neurolite, which helps identify stroke-damaged areas in the brain; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 for detecting cardiovascular disease; and Gallium-67, utilized in identifying infections and cancerous tumors. They also offer the Automated Bone Scan Index, a tool for quantifying prostate cancer burden from bone scans; PYLARIFY, designed for visualizing lymph nodes, bone, and soft tissue metastases to detect recurrent or metastatic prostate cancer; and Cobalt (Co 57), a non-pharmaceutical radiochemical. In the therapeutic space, Lantheus provides AZEDRA, a radiopharmaceutical treatment for both adult and pediatric patients, and RELISTOR, a medication addressing opioid-induced constipation. The company's robust development pipeline includes promising innovations such as flurpiridaz F 18, an agent for assessing myocardial blood flow; 1095, a PSMA-targeted iodine-131 labeled small molecule; LMI 1195 for neuroblastoma tumors in both children and adults; PYLARIFY AI, an AI-powered medical device software for standardized quantitative analysis of PSMA PET/CT images in prostate cancer; and leronlimab, an investigational humanized monoclonal antibody.
LNTH (Lantheus Holdings, Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $7.15B, a trailing P/E of 25.47, a beta of -0.04 versus the broader market, a 52-week range of 47.25-111.46, average daily share volume of 911K, a public-listing history dating back to 2015, approximately 808 full-time employees. These structural characteristics shape how LNTH stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of -0.04 indicates LNTH has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a long put on LNTH?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
Current LNTH snapshot
As of June 29, 2026, spot at $109.49, ATM IV 46.80%, IV rank 7.56%, expected move 13.42%. The long put on LNTH below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.
Why this long put structure on LNTH specifically: LNTH IV at 46.80% is on the cheap side of its 1-year range, which favors premium-buying structures like a LNTH long put, with a market-implied 1-standard-deviation move of approximately 13.42% (roughly $14.69 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated LNTH expiries trade a higher absolute premium for lower per-day decay. Position sizing on LNTH should anchor to the underlying notional of $109.49 per share and to the trader's directional view on LNTH stock.
LNTH long put setup
The LNTH long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With LNTH near $109.49, the first option leg uses a $110.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed LNTH chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 LNTH shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $110.00 | $5.25 |
LNTH long put risk and reward
- Net Premium / Debit
- -$525.00
- Max Profit (per contract)
- $10,474.00
- Max Loss (per contract)
- -$525.00
- Breakeven(s)
- $104.75
- Risk / Reward Ratio
- 19.950
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
LNTH long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on LNTH. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$10,474.00 |
| $24.22 | -77.9% | +$8,053.23 |
| $48.43 | -55.8% | +$5,632.45 |
| $72.63 | -33.7% | +$3,211.68 |
| $96.84 | -11.6% | +$790.90 |
| $121.05 | +10.6% | -$525.00 |
| $145.26 | +32.7% | -$525.00 |
| $169.46 | +54.8% | -$525.00 |
| $193.67 | +76.9% | -$525.00 |
| $217.88 | +99.0% | -$525.00 |
When traders use long put on LNTH
Long puts on LNTH hedge an existing long LNTH stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying LNTH exposure being hedged.
LNTH thesis for this long put
The market-implied 1-standard-deviation range for LNTH extends from approximately $94.80 on the downside to $124.18 on the upside. A LNTH long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long LNTH position with one put per 100 shares held. Current LNTH IV rank near 7.56% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on LNTH at 46.80%. As a Healthcare name, LNTH options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to LNTH-specific events.
LNTH long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. LNTH positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move LNTH alongside the broader basket even when LNTH-specific fundamentals are unchanged. Long-premium structures like a long put on LNTH are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current LNTH chain quotes before placing a trade.
Frequently asked questions
- What is a long put on LNTH?
- A long put on LNTH is the long put strategy applied to LNTH (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With LNTH stock trading near $109.49, the strikes shown on this page are snapped to the nearest listed LNTH chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are LNTH long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the LNTH long put priced from the end-of-day chain at a 30-day expiry (ATM IV 46.80%), the computed maximum profit is $10,474.00 per contract and the computed maximum loss is -$525.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a LNTH long put?
- The breakeven for the LNTH long put priced on this page is roughly $104.75 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current LNTH market-implied 1-standard-deviation expected move is approximately 13.42%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on LNTH?
- Long puts on LNTH hedge an existing long LNTH stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying LNTH exposure being hedged.
- How does current LNTH implied volatility affect this long put?
- LNTH ATM IV is at 46.80% with IV rank near 7.56%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.